BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Clinical trials for BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3) explained in plain language.
Never miss a new study
Get alerted when new BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3) trials appear
Sign up with your email to follow new studies for BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can diet, exercise, and therapy supercharge chemo for breast cancer?
Disease control Recruiting nowThis study is testing whether a special wellness program during chemotherapy can help women with early-stage breast cancer get better results from their treatment. 214 women will be randomly assigned to either receive standard care or a program that includes guided exercise, nutr…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: NA • Sponsor: Hospital Clinic of Barcelona • Aim: Disease control
Last updated Mar 27, 2026 12:38 UTC
-
Blood test could spare breast cancer patients from harsh chemo
Disease control Recruiting nowThis study is testing a personalized approach to reduce chemotherapy for women with a common type of early-stage breast cancer. It uses a simple blood test to see if a targeted pill (dalpiciclib) combined with hormone therapy works as well as standard chemo before surgery. The go…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: PHASE2 • Sponsor: Peking University People's Hospital • Aim: Disease control
Last updated Mar 24, 2026 12:03 UTC
-
Breathing aid could shield hearts from radiation damage
Disease control Recruiting nowThis study is testing if using a CPAP breathing machine during radiation therapy can lower the amount of radiation that reaches the heart and lungs of breast cancer patients. The goal is to reduce the risk of long-term heart and lung problems that can be caused by radiation treat…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: PHASE2, PHASE3 • Sponsor: Universitaire Ziekenhuizen KU Leuven • Aim: Disease control
Last updated Mar 16, 2026 15:24 UTC
-
New test aims to personalize breast cancer care
Diagnosis Recruiting nowThis study is observing how a new genomic test called HER2DX affects the decisions doctors make for patients with early-stage HER2-positive breast cancer. It will see if the test helps doctors choose the best type and timing of drug therapy with more confidence. The study is not …
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Sponsor: European Institute of Oncology • Aim: Diagnosis
Last updated Apr 01, 2026 14:43 UTC
-
New blood test could spot breast cancer early, study aims to prove it
Diagnosis Recruiting nowThis study is testing a new blood test designed to detect breast cancer early. Researchers will enroll 300 women—some with breast cancer and some without—to see if specific markers in the blood can accurately identify the disease. The goal is to develop a simple, non-invasive too…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Sponsor: Oncoliq US Inc • Aim: Diagnosis
Last updated Mar 25, 2026 14:07 UTC
-
Can your phone ease breast cancer treatment? new app trial seeks answers
Symptom relief Recruiting nowThis study is testing whether a smartphone app can help people with early-stage breast cancer feel better while taking hormone therapy. The app provides education and self-care tips to help manage common side effects like fatigue, pain, and sleep problems. Researchers will compar…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: PHASE3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Symptom relief
Last updated Mar 30, 2026 14:34 UTC
-
Gentle touch therapy trial offers hope for women suffering Long-Term breast cancer pain
Symptom relief Recruiting nowThis small UK study is testing whether ScarWork, a gentle manual therapy, can help reduce persistent pain that some women experience after breast cancer surgery and radiation. Forty women who have completed treatment at least six months ago and still have pain will be randomly as…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: NA • Sponsor: University College London Hospitals • Aim: Symptom relief
Last updated Mar 30, 2026 14:33 UTC
-
New hope for cancer Survivors' debilitating hot flashes?
Symptom relief Recruiting nowThis study is testing if a daily pill called fezolinetant can reduce the frequency and severity of hot flashes in women who are taking hormone therapy for early-stage breast cancer. Researchers will compare the pill's effects against a placebo in 92 participants over 12 weeks. Th…
Matched conditions: BREAST CANCER EARLY STAGE BREAST CANCER (STAGE 1-3)
Phase: PHASE2 • Sponsor: Yale University • Aim: Symptom relief
Last updated Mar 16, 2026 15:25 UTC